Maria E. Dan
Impact in
-
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Hematopoietic Stem Cell Transplantation 5
- Oncology 8
- CAR-T cell therapy research 2
- Co-authors
- Ayad M Al-Katib (4 shared papers)Ramzi M. Mohammad (3 shared papers)Lyle L. Sensenbrenner (4 shared papers)Joseph P. Uberti (4 shared papers)David S. Eilender (2 shared papers)Mary Laura Varterasian (2 shared papers)Ayad Al-Katib (2 shared papers)Patricia Mucci LoRusso (2 shared papers)
- Journals
- Neurology (2 papers)Journal of Immunotherapy (2 papers)Journal of Clinical Oncology (1 paper)Molecules (1 paper)Eurosurveillance (1 paper)
- Partner nations
- United StatesRomaniaPakistan
In The Last Decade
Maria E. Dan
25 papers receiving 494 citations
Peers
Comparison fields: 5 of 77
- Oncology 159
- Genetics 53
- Hematology 53
- Toxicology 16
- Pathology and Forensic Medicine 65
Countries citing papers authored by Maria E. Dan
This map shows the geographic impact of Maria E. Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. Dan more than expected).
Fields of papers citing papers by Maria E. Dan
This network shows the impact of papers produced by Maria E. Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. Dan. The network helps show where Maria E. Dan may publish in the future.
Co-authors
The 25 scholars most cited alongside Maria E. Dan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 102 | |
| 2 | Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. | 2000 | 85 |
| 3 | Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. | 1990 | 51 |
| 4 | 2022 | 34 | |
| 5 | Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates. | 1993 | 28 |
| 6 | 1993 | 25 | |
| 7 | 1993 | 23 | |
| 8 | Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation. | 1994 | 23 |
| 9 | 1999 | 23 | |
| 10 | 1996 | 21 | |
| 11 | 2016 | 17 | |
| 12 | 1999 | 16 | |
| 13 | Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma. | 2002 | 15 |
| 14 | 1994 | 10 | |
| 15 | Strategies for managing refractoriness to platelet transfusions. | 2003 | 9 |
| 16 | 1995 | 7 | |
| 17 | [Subacute bacterial endocarditis due to Pasteurella pneumotropica. Case Report]. | 2006 | 7 |
| 18 | 2002 | 5 | |
| 19 | 2007 | 4 | |
| 20 | [Fungi as emergent etiologic agents in ventilator-associated pneumonia after cardiac surgery]. | 2011 | 3 |
About Maria E. Dan
Maria E. Dan is a scholar working on Hematology, Oncology, Immunology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 29 papers that have together received 516 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (5 papers), Antibiotic Resistance in Bacteria (3 papers), Antifungal resistance and susceptibility (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (2 papers), Antibiotic Use and Resistance (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Nosocomial Infections in ICU (2 papers). The work is most often cited by research in Oncology (159 citations), Genetics (53 citations), Hematology (53 citations), Toxicology (16 citations) and Pathology and Forensic Medicine (65 citations). Maria E. Dan has collaborated with scholars based in United States, Romania and Pakistan. Frequent co-authors include Ayad M Al-Katib, Ramzi M. Mohammad, Lyle L. Sensenbrenner, Joseph P. Uberti, David S. Eilender, Mary Laura Varterasian, Ayad Al-Katib, Patricia Mucci LoRusso, Muhammad S. Shurafa and Anthony J. Murgo. Their work appears in journals such as Neurology, Journal of Immunotherapy, Journal of Clinical Oncology, Molecules and Eurosurveillance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.